The effects of the dual 5α-reductase inhibitor dutasteride on localized prostate cancer—results from a 4-month pre-radical prostatectomy study
- 20 September 2006
- journal article
- research article
- Published by Wiley in The Prostate
- Vol. 66 (15) , 1674-1685
- https://doi.org/10.1002/pros.20499
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Androgen-Induced Regrowth in the Castrated Rat Ventral Prostate: Role of 5α-Reductase1Endocrinology, 1999
- Effect of early treatment of prostate cancer with the 5α-reductase inhibitor turosteride in Dunning R3327 prostatic carcinoma in ratsThe Prostate, 1998
- Effect of the dual 5α-reductase inhibitor Pnu 157706 on the growth of dunning R3327 prostatic carcinoma in the ratThe Journal of Steroid Biochemistry and Molecular Biology, 1998
- Effect of turosteride, a 5α-reductase inhibitor, on the Dunning R3327 rat prostatic carcinomaThe Prostate, 1997
- Treatment with finasteride following radical prostatectomy for prostate cancerUrology, 1995
- Finasteride dose-dependently reduces the proliferation rate of the LnCap human prostatic cancer cell line in vitroUrology, 1995
- Multicenter, Randomized, Double-Blind, Placebo Controlled Study to Investigate the Effect of Finasteride (MK-906) on Stage D Prostate CancerJournal of Urology, 1992
- Response of rat and human prostatic cancers to the novel 5α‐reductase inhibitor, SK&F 105657The Prostate, 1992
- STUDIES ON PROSTATIC CANCERArchives of Surgery, 1941
- THE QUESTION OF CASTRATION FOR ENLARGED PROSTATEAnnals of Surgery, 1896